Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_05554 | 54 | 1.12 | Mlig455_062512 | Neo: - Age: - |
Mlig455_062512 {REF} {Length: 1169} {RNA1310_55738} {RNA815_31370.1} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | - | - | - | - | |
RegionR2 | - | - | - | - | |
RegionR3 | - | - | - | - | |
RegionR4 | - | - | - | - | |
RegionR5 | - | - | - | - | |
RegionR6 | - | - | - | - | |
RegionR7 | - | - | - | - | |
RegionR8 | - | - | - | - |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | - | - | - | - | |
RegenerationR2 | - | - | - | - | |
RegenerationR3 | - | - | - | - | |
RegenerationR4 | - | - | - | - | |
RegenerationR5 | - | - | - | - | |
RegenerationR6 | - | - | - | - | |
RegenerationBL | - | - | - | - | |
RegenerationTP | - | - | - | - |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_05554 | 54 | 1.12 | Mlig455_062512 | Neo: - Age: - |
1 | 1.000 | - | - | - | - | - | Mlig455_062512 {REF} {Length: 1169} {RNA1310_55738} {RNA815_31370.1} | |
2. | MligTC455_07961 | 191 | 3.98 | Mlig455_051526 | Neo: - Age: - Region-enriched R8: 7.862/0.00000 Regeneration-enriched R5: 7.080 |
0.995 | 0.995 | - | - | - | - | - | Mlig455_051526 {REF} {Length: 437} {RNA815_63444} | |
3. | MligTC455_33925 | 519 | 10.82 | Mlig455_020716, Mlig455_020784 | Neo: - Age: Down-Down-Up Region-enriched R8: 6.564/0.00000 |
0.993 | 0.993 | - | - | - | - | - | Mlig455_020716 {REF} {Length: 1635} {Pfam: Amastin surface glycoprotein [PF07344.13, score=21.1]} {RNA1310_25321} {RNA815_36976} Mlig455_020784 {REF} {Length: 2274} {Pfam: Amastin surface glycoprotein [PF07344.13, score=22.1]} {RNA1310_25321} {RNA815_36976} |
|
4. | MligTC455_39971 | 147 | 3.07 | Mlig455_034549 | Neo: - Age: - Region-enriched R8: 4.475/0.00030 |
0.993 | 0.993 | - | - | - | - | - | Mlig455_034549 {REF} {Length: 2181} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=33.7]} {RNA1310_27858} {RNA815_17949} | |
5. | MligTC455_39972 | 142 | 2.96 | Mlig455_064814 | Neo: - Age: - Region-enriched R8: 4.539/0.00054 |
0.993 | 0.993 | - | - | - | - | - | Mlig455_064814 {REF} {Length: 2232} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=34.6]} {RNA1310_27858} {RNA815_17949} | |
6. | MligTC455_03038 | 227 | 4.72 | Mlig455_060778 | Neo: - Age: Down-Up-Down Region-enriched R8: 6.261/0.00000 |
0.991 | 0.991 | - | - | - | - | - | Mlig455_060778 {REF} {Length: 4155} {TRANSSPLICED} {tRNA: Val(CAC),pseudo, score=27.8} {Mouse: ENSMUSG00000059854, Hydin, HYDIN, axonemal central pair apparatus protein, [Score=55.1, Expect=5e-07]} {RNA1509_16236} {RNA1310_4008} {RNA815_2550} | |
7. | MligTC455_44435 | 628 | 13.08 | Mlig455_062382, Mlig455_062409 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=-0.421 Region-enriched R8: 5.635/0.00000 |
DDI2, HMCN1 | 0.991 | 0.991 | - | - | - | - | - | Mlig455_062382 {REF} {Length: 12544} {TRANSSPLICED} {Pfam: Aspartyl protease [PF09668.12, score=182.5]; gag-polyprotein putative aspartyl protease [PF13975.8, score=76.1]; Thrombospondin type 1 domain [PF00090.21, score=72.3]; Spondin-like TSP1 domain [PF19028.2, score=68.4]; Arginine repressor, C-terminal domain [PF02863.20, score=43.6]; Aspartyl protease [PF13650.8, score=34.4]; Putative vacuolating cytotoxin [PF03077.16, score=29.0]; Ubiquitin-2 like Rad60 SUMO-like [PF11976.10, score=26.1]; Thrombospondin type 1 domain [PF19030.2, score=23.0]; CCN3 Nov like TSP1 domain [PF19035.2, score=22.2]; Retroviral aspartyl protease [PF00077.22, score=19.1]} {Human: ENSG00000197312, DDI2, DNA damage inducible 1 homolog 2, [Score=279, Expect=2e-82]} {Mouse: ENSMUSG00000078515, Ddi2, DNA-damage inducible protein 2, [Score=266, Expect=5e-78]; ENSMUSG00000047619, Ddi1, DNA-damage inducible 1, [Score=255, Expect=4e-74]} {Dmel: FBgn0030753, rngo, rings lost, [Score=275, Expect=1e-80]} {Celegans: WBGene00015308, ddi-1, Dna (DNA) Damage Inducible homolog, [Score=131, Expect=5e-32]} {Smed: dd_Smed_v6_2764_0_1, dd_Smed_v6_2764_0_1, [Score=213, Expect=1e-60]} {RNA1509_6950} {RNA1310_548} {RNA815_300} Mlig455_062409 {REF} {Length: 19342} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=78.9]; Thrombospondin type 1 domain [PF00090.21, score=74.6]; Arginine repressor, C-terminal domain [PF02863.20, score=41.0]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=40.0]; CCN3 Nov like TSP1 domain [PF19035.2, score=32.2]; Putative vacuolating cytotoxin [PF03077.16, score=30.3]; Thrombospondin type 1 domain [PF19030.2, score=23.2]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=90.1, Expect=7e-17]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=90.5, Expect=4e-17]} {Dmel: FBgn0050046, CG30046, [Score=52.4, Expect=8e-06]} {Celegans: WBGene00000083, adt-2, ADAMTS family; ADAMTS-like protease, [Score=87.8, Expect=1e-16]} {Smed: dd_Smed_v6_628_0_1, dd_Smed_v6_628_0_1, [Score=159, Expect=6e-39]} {RNA1509_21415, RNA1509_6950} {RNA1310_548, RNA1509_21415, RNA1509_6950} {RNA1509_21415, RNA1509_6950, RNA815_300} |
8. | MligTC455_20782 | 91 | 1.9 | Mlig455_066519 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-1.321 Region-enriched R8: 5.950/0.00576 |
0.99 | 0.990 | - | - | - | - | - | Mlig455_066519 {REF} {Length: 3710} {RNA1509_53671} {RNA1310_35957.1} {RNA815_13121.1} | |
9. | MligTC455_38796 | 1266 | 26.37 | Mlig455_060220, Mlig455_060235 | Neo: - Age: Down-Down-Up Region-enriched R8: 6.521/0.00003 |
BACE1 | 0.988 | 0.988 | - | - | - | - | - | Mlig455_060220 {REF} {Length: 1841} {Pfam: Eukaryotic aspartyl protease [PF00026.25, score=72.8]; Xylanase inhibitor C-terminal [PF14541.8, score=19.9]} {Human: ENSG00000186318, BACE1, beta-secretase 1, [Score=215, Expect=3e-63]} {Mouse: ENSMUSG00000032086, Bace1, beta-site APP cleaving enzyme 1, [Score=214, Expect=5e-63]} {Dmel: FBgn0032304, CG17134, [Score=56.2, Expect=3e-08]} {Celegans: WBGene00000218, asp-5, ASpartyl Protease, [Score=47.8, Expect=1e-05]} {RNA1509_48153} {RNA1310_17192, RNA1509_48153} {RNA1509_48153, RNA815_50706} Mlig455_060235 {REF} {Length: 1482} {Human: ENSG00000186318, BACE1, beta-secretase 1, [Score=119, Expect=2e-29]} {Mouse: ENSMUSG00000032086, Bace1, beta-site APP cleaving enzyme 1, [Score=118, Expect=1e-28]} {RNA1509_48153} {RNA1310_17192} {RNA815_51940} |
10. | MligTC455_53279 | 2935 | 61.14 | Mlig455_017965 | Neo: - Age: Down-Up-Down Region-specific R8: 3.606 Region-enriched R8: 3.165/0.00000 Regeneration-downregulated BL: -2.902 Regeneration-depleted BL: -2.902 |
0.986 | 0.986 | - | - | - | - | - | Mlig455_017965 {REF} {Length: 1023} {RNA1509_20769, RNA1509_34269} {RNA1310_44808, RNA1509_20769, RNA1509_34269} {RNA1509_20769, RNA1509_34269, RNA815_8213} | |
11. | MligTC455_14375 | 163 | 3.4 | Mlig455_056945 | Neo: - Age: - |
0.985 | 0.985 | - | - | - | - | - | Mlig455_056945 {REF} {Length: 1764} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=49.6]} {Smed: dd_Smed_v6_32358_0_1, dd_Smed_v6_32358_0_1, [Score=94.4, Expect=4e-22]} {RNA1509_48719} {RNA1310_16266.1} {RNA815_10544.2} | |
12. | MligTC455_20781 | 5503 | 114.65 | Mlig455_066518 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.978 Region-enriched R8: 6.430/0.00000 |
FBN2 | 0.985 | 0.985 | - | - | - | - | - | Mlig455_066518 {REF} {Length: 6133} {Pfam: EGF domain [PF12947.9, score=539.9]; Calcium-binding EGF domain [PF07645.17, score=534.2]; Complement Clr-like EGF-like [PF12662.9, score=301.4]; EGF-like domain [PF00008.29, score=202.5]; Human growth factor-like EGF [PF12661.9, score=158.8]; MSP1 EGF domain 1 [PF12946.9, score=133.7]; Coagulation Factor Xa inhibitory site [PF14670.8, score=101.2]; Pvs28 EGF domain [PF06247.13, score=76.5]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=27.8]} {Human: ENSG00000138829, FBN2, fibrillin 2, [Score=348, Expect=8e-98]} {Mouse: ENSMUSG00000024598, Fbn2, fibrillin 2, [Score=350, Expect=2e-98]} {Dmel: FBgn0053196, dpy, dumpy, [Score=343, Expect=2e-96]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [RH, Score=268, Expect=2e-72]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=426, Expect=1e-123]} {RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746, RNA1509_770} {RNA1310_1209, RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746} {RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746, RNA815_317.1} |
13. | MligTC455_16918 | 1218 | 25.38 | Mlig455_039085, Mlig455_042780 | Neo: - Age: Up-Down-Down Region-enriched R8: 5.308/0.00000 |
MECOM | 0.984 | 0.984 | - | - | - | - | - | Mlig455_039085 {REF} {Length: 4916} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=99.3]; C2H2-type zinc finger [PF13894.8, score=76.6]; Zinc-finger double domain [PF13465.8, score=72.4]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=41.2]; C2H2-type zinc finger [PF13912.8, score=35.0]; Drought induced 19 protein (Di19), zinc-binding [PF05605.14, score=25.5]; Zinc-finger of C2H2 type [PF12874.9, score=20.9]; C2H2-type zinc-finger domain [PF13909.8, score=18.4]} {Human: ENSG00000085276, MECOM, MDS1 and EVI1 complex locus, [RH, Score=147, Expect=6e-35]; ENSG00000142611, PRDM16, PR/SET domain 16, [RH, Score=145, Expect=3e-34]} {Mouse: ENSMUSG00000027684, Mecom, MDS1 and EVI1 complex locus, [RH, Score=146, Expect=2e-35]; ENSMUSG00000039410, Prdm16, PR domain containing 16, [RH, Score=146, Expect=9e-35]} {Dmel: FBgn0045852, ham, hamlet, [RH, Score=149, Expect=1e-36]} {Celegans: WBGene00015646, mlt-10, [Score=172, Expect=3e-44]} {Smed: dd_Smed_v6_22685_0_1, dd_Smed_v6_22685_0_1, [RH, Score=145, Expect=5e-38]} {RNA1509_21422} {RNA1310_3577} {RNA815_16096} Mlig455_042780 {REF} {Length: 3778} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=70.4]; Zinc-finger double domain [PF13465.8, score=59.4]; C2H2-type zinc finger [PF13894.8, score=36.4]; Drought induced 19 protein (Di19), zinc-binding [PF05605.14, score=29.7]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=29.0]; C2H2-type zinc finger [PF13912.8, score=28.6]; Zinc-finger of C2H2 type [PF12874.9, score=24.8]; C2H2-type zinc-finger domain [PF13909.8, score=21.2]; GAGA factor [PF09237.13, score=19.5]; C2H2 type zinc-finger (2 copies) [PF12756.9, score=18.9]} {Human: ENSG00000085276, MECOM, MDS1 and EVI1 complex locus, [RH, Score=141, Expect=6e-35]; ENSG00000142611, PRDM16, PR/SET domain 16, [RH, Score=139, Expect=3e-34]} {Mouse: ENSMUSG00000027684, Mecom, MDS1 and EVI1 complex locus, [RH, Score=141, Expect=3e-35]; ENSMUSG00000039410, Prdm16, PR domain containing 16, [RH, Score=140, Expect=1e-34]} {Dmel: FBgn0032707, CG10348, [RH, Score=144, Expect=8e-37]} {Celegans: WBGene00001207, egl-43, Egl-43, [RH, Score=98.2, Expect=2e-22]} {Smed: dd_Smed_v6_22685_0_1, dd_Smed_v6_22685_0_1, [RH, Score=144, Expect=9e-39]} {RNA1509_21422} {RNA1310_3577} {RNA815_16096} |
14. | MligTC455_45987 | 1592 | 33.17 | Mlig455_024379, Mlig455_024495 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.664 Region-specific R8: 3.405 Region-enriched R8: 3.716/0.00000 Regeneration-depleted BL: -2.612 |
PKDREJ | 0.984 | 0.984 | - | - | - | - | - | Mlig455_024379 {REF} {Length: 9101} {Pfam: PKD domain [PF18911.2, score=34.9]; PKD domain [PF00801.22, score=21.5]} {RNA1509_1257} {RNA1310_126.1} {RNA815_58} Mlig455_024495 {REF} {Length: 8484} {Pfam: Polycystin cation channel [PF08016.14, score=333.9]; PLAT/LH2 domain [PF01477.25, score=69.5]; PKD domain [PF18911.2, score=32.8]; Ion transport protein [PF00520.33, score=31.6]; PKD domain [PF00801.22, score=19.8]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [RH, Score=346, Expect=8e-95]} {Mouse: ENSMUSG00000052496, Pkdrej, polycystin (PKD) family receptor for egg jelly, [RH, Score=327, Expect=4e-89]; ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [RH, Score=319, Expect=7e-87]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=167, Expect=3e-41]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=198, Expect=3e-52]} {Smed: dd_Smed_v6_10962_0_1, dd_Smed_v6_10962_0_1, [Score=592, Expect=9e-172]} {RNA1509_1257} {RNA1310_126.1} {RNA815_58} |
15. | MligTC455_20780 | 8892 | 185.26 | Mlig455_040314 | Neo: - Age: logFC(26M/2M)=-1.054 Region-enriched R8: 6.072/0.00000 |
NOTCH2 | 0.981 | 0.981 | - | - | - | - | - | Mlig455_040314 {REF} {Length: 15786} {Pfam: EGF domain [PF12947.9, score=500.6]; Calcium-binding EGF domain [PF07645.17, score=489.8]; Complement Clr-like EGF-like [PF12662.9, score=268.7]; EGF-like domain [PF00008.29, score=175.9]; Human growth factor-like EGF [PF12661.9, score=135.4]; MSP1 EGF domain 1 [PF12946.9, score=91.5]; von Willebrand factor type D domain [PF00094.27, score=75.8]; Coagulation Factor Xa inhibitory site [PF14670.8, score=51.8]; Pvs28 EGF domain [PF06247.13, score=34.2]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=25.7]} {Human: ENSG00000134250, NOTCH2, notch 2, [Score=246, Expect=4e-64]; ENSG00000138829, FBN2, fibrillin 2, [Score=237, Expect=3e-61]} {Mouse: ENSMUSG00000027878, Notch2, notch 2, [Score=249, Expect=6e-65]} {Dmel: FBgn0053196, dpy, dumpy, [Score=343, Expect=2e-93]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [RH, Score=254, Expect=5e-67]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=415, Expect=3e-115]} {RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_770, RNA1509_9237} {RNA1310_1209, RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_9237} {RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_9237, RNA815_317.1} |
16. | MligTC455_04474 | 114 | 2.37 | Mlig455_039605 | Neo: - Age: logFC(26M/2M)=-0.389 Region-enriched R8: 5.608/0.00012 |
HMCN1 | 0.98 | 0.980 | - | - | - | - | - | Mlig455_039605 {REF} {Length: 4319} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=405.5]; Spondin-like TSP1 domain [PF19028.2, score=340.3]; Thrombospondin type 1 domain [PF19030.2, score=125.1]; Scavenger receptor cysteine-rich domain [PF00530.20, score=57.7]; CCN3 Nov like TSP1 domain [PF19035.2, score=48.4]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=292, Expect=4e-80]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=288, Expect=7e-79]} {Dmel: FBgn0284221, Sema5c, Semaphorin 5c, [Score=156, Expect=3e-38]} {Celegans: WBGene00016468, C36B7.5, [RH, Score=199, Expect=7e-52]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=264, Expect=9e-72]} {RNA1509_12135} {RNA1310_3277, RNA1509_12135} {RNA1509_12135, RNA815_5276} |
17. | MligTC455_11926 | 101 | 2.11 | Mlig455_021319 | Neo: - Age: - Region-enriched R7: 4.905/0.00107 |
0.98 | 0.980 | - | - | - | - | - | Mlig455_021319 {REF} {Length: 2758} {Pfam: Mab-21 protein [PF03281.16, score=23.9]} {RNA1509_41055} {RNA1310_11481.1} {RNA815_44675} | |
18. | MligTC455_36259 | 270 | 5.63 | Mlig455_012889 | Neo: - Age: - Region-enriched R8: 5.567/0.00000 Regeneration-depleted R6: -6.631 |
WNT7B | 0.98 | 0.980 | - | - | - | - | - | Mlig455_012889 {REF} {Length: 1741} {Pfam: wnt family [PF00110.21, score=249.8]} {Human: ENSG00000188064, WNT7B, Wnt family member 7B, [Score=153, Expect=3e-42]; ENSG00000105989, WNT2, Wnt family member 2, [Score=149, Expect=2e-40]; ENSG00000002745, WNT16, Wnt family member 16, [Score=147, Expect=1e-39]; ENSG00000154764, WNT7A, Wnt family member 7A, [Score=147, Expect=9e-40]} {Mouse: ENSMUSG00000029671, Wnt16, wingless-type MMTV integration site family, member 16, [Score=155, Expect=5e-43]; ENSMUSG00000022382, Wnt7b, wingless-type MMTV integration site family, member 7B, [Score=152, Expect=4e-42]; ENSMUSG00000022996, Wnt10b, wingless-type MMTV integration site family, member 10B, [Score=150, Expect=7e-41]} {Dmel: FBgn0284084, wg, wingless, [Score=133, Expect=4e-34]} {Celegans: WBGene00001188, egl-20, Wnt homolog, [Score=130, Expect=6e-34]} {Smed: dd_Smed_v6_28398_0_1, dd_Smed_v6_28398_0_1, [Score=214, Expect=3e-65]} {RNA1509_58183} {RNA1310_17932, RNA1509_58183} {RNA1509_58183, RNA815_30269} |
19. | MligTC455_30420 | 109 | 2.28 | Mlig455_054202, Mlig455_060746 | Neo: - Age: - |
TMEM26 | 0.979 | 0.979 | - | - | - | - | - | Mlig455_054202 {REF} {Length: 2118} {Pfam: Transmembrane protein 26 [PF09772.11, score=227.2]} {Human: ENSG00000196932, TMEM26, transmembrane protein 26, [Score=126, Expect=7e-33]} {Mouse: ENSMUSG00000060044, Tmem26, transmembrane protein 26, [RH, Score=134, Expect=7e-36]} {Dmel: FBgn0039429, CG14238, [Score=172, Expect=5e-49]} {Celegans: WBGene00022469, Y119C1B.3, [Score=139, Expect=2e-37]} {Smed: dd_Smed_v6_30929_0_1, dd_Smed_v6_30929_0_1, [Score=144, Expect=1e-39]} {RNA1310_35836} {RNA815_14435} Mlig455_060746 {REF} {Length: 3939} {Pfam: Transmembrane protein 26 [PF09772.11, score=226.7]} {Human: ENSG00000196932, TMEM26, transmembrane protein 26, [Score=127, Expect=5e-33]} {Mouse: ENSMUSG00000060044, Tmem26, transmembrane protein 26, [RH, Score=136, Expect=1e-36]} {Dmel: FBgn0039429, CG14238, [Score=171, Expect=8e-49]} {Celegans: WBGene00022469, Y119C1B.3, [Score=139, Expect=2e-37]} {Smed: dd_Smed_v6_30929_0_1, dd_Smed_v6_30929_0_1, [Score=144, Expect=1e-39]} {RNA1310_35836} {RNA815_14435} |
20. | MligTC455_13018 | 1993 | 41.51 | Mlig455_033923 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.482 Region-enriched R8: 5.842/0.00000 |
0.978 | 0.978 | - | - | - | - | - | Mlig455_033923 {REF} {Length: 1258} {RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130} {RNA1310_45334, RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130} {RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130, RNA815_5573.2} | |
21. | MligTC455_47410 | 144 | 3 | Mlig455_066471 | Neo: - Age: - |
0.978 | 0.978 | - | - | - | - | - | Mlig455_066471 {REF} {Length: 690} {NoTransDecoderORF} {RNA1509_9488} {RNA1310_3197} {RNA815_3130} | |
22. | MligTC455_49843 | 70 | 1.46 | Mlig455_058264, Mlig455_058281, Mlig455_070786 | Neo: - Age: - |
CHRNA3, CHRNA7 | 0.977 | 0.977 | - | - | - | - | - | Mlig455_058264 {REF} {Length: 2377} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.7]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=224, Expect=4e-66]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=223, Expect=8e-66]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=220, Expect=8e-65]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=219, Expect=6e-65]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=213, Expect=4e-62]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=240, Expect=3e-72]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=229, Expect=7e-69]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=227, Expect=1e-67]} {RNA1310_31785} {RNA815_40862} Mlig455_058281 {REF} {Length: 2912} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=179.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=105.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=238, Expect=4e-71]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=236, Expect=1e-70]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=231, Expect=2e-69]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=229, Expect=4e-68]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=240, Expect=3e-72]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=232, Expect=3e-69]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=231, Expect=7e-69]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=228, Expect=3e-68]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=252, Expect=2e-76]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=250, Expect=1e-76]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=239, Expect=7e-72]} {RNA1310_31785} {RNA815_40862} Mlig455_070786 {REF} {Length: 1486} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=36.1]} {RNA1310_31785} {RNA815_43410} |
23. | MligTC455_31518 | 19118 | 398.29 | Mlig455_053864, Mlig455_053878 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=2.053 Region-enriched R8: 7.674/0.00000 |
PI16 | 0.976 | 0.976 | - | - | - | - | - | Mlig455_053864 {REF} {Length: 1794} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=56.1]; Kringle domain [PF00051.20, score=52.3]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=100, Expect=1e-22]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=99.0, Expect=3e-22]} {Dmel: FBgn0038126, CG8483, [Score=102, Expect=1e-23]} {Celegans: WBGene00011724, scl-18, SCP-Like extracellular protein, [RH, Score=73.2, Expect=1e-14]} {Smed: dd_Smed_v6_924_0_1, dd_Smed_v6_924_0_1, [RH, Score=128, Expect=3e-35]} {RNA1509_603} {RNA1310_25676} {RNA815_7928} Mlig455_053878 {REF} {Length: 1368} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=56.1]; Kringle domain [PF00051.20, score=52.3]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=100, Expect=1e-22]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=99.0, Expect=3e-22]} {Dmel: FBgn0038126, CG8483, [Score=102, Expect=1e-23]} {Celegans: WBGene00011724, scl-18, SCP-Like extracellular protein, [RH, Score=73.2, Expect=1e-14]} {Smed: dd_Smed_v6_924_0_1, dd_Smed_v6_924_0_1, [RH, Score=128, Expect=3e-35]} {RNA1509_603} {RNA1310_25676} {RNA815_7928} |
24. | MligTC455_31519 | 9556 | 199.07 | Mlig455_055347 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.365 Region-enriched R8: 7.870/0.00000 |
PI16 | 0.976 | 0.976 | - | - | - | - | - | Mlig455_055347 {REF} {Length: 1681} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=56.5]; Kringle domain [PF00051.20, score=52.7]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=84.3, Expect=2e-17]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=82.4, Expect=6e-17]} {Dmel: FBgn0038126, CG8483, [Score=97.4, Expect=2e-22]} {Celegans: WBGene00003055, lon-1, LONg, [Score=65.1, Expect=9e-12]} {Smed: dd_Smed_v6_433_0_1, dd_Smed_v6_433_0_1, [Score=111, Expect=3e-29]} {RNA1509_603} {RNA1310_25676} {RNA815_7928} |
25. | MligTC455_31520 | 9547 | 198.9 | Mlig455_055402 | Neo: - Age: logFC(26M/2M)=-0.427 Region-enriched R8: 7.718/0.00000 |
PI16 | 0.976 | 0.976 | - | - | - | - | - | Mlig455_055402 {REF} {Length: 1363} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=27.4]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=69.3, Expect=4e-13]; ENSG00000173401, GLIPR1L1, GLIPR1 like 1, [Score=67.8, Expect=4e-13]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=71.2, Expect=7e-14]} {Dmel: FBgn0038126, CG8483, [Score=55.8, Expect=6e-09]} {Celegans: WBGene00009890, scl-9, SCP-Like extracellular protein, [Score=50.4, Expect=1e-07]} {Smed: dd_Smed_v6_924_0_2, dd_Smed_v6_924_0_2, [Score=87.0, Expect=1e-21]} {RNA1509_603} {RNA1310_25676} {RNA815_7928} |
26. | MligTC455_22921 | 848 | 17.66 | Mlig455_048030 | Neo: - Age: - Region-enriched R8: 6.496/0.00000 Regeneration-downregulated BL: -8.561 Regeneration-depleted BL: -8.561 |
CNTNAP1 | 0.974 | 0.974 | - | - | - | - | - | Mlig455_048030 {REF} {Length: 2506} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=31.2]; Spondin-like TSP1 domain [PF19028.2, score=23.9]; Thrombospondin type 1 domain [PF19030.2, score=20.8]} {Human: ENSG00000108797, CNTNAP1, contactin associated protein 1, [Score=65.5, Expect=3e-11]} {Mouse: ENSMUSG00000017167, Cntnap1, contactin associated protein-like 1, [Score=69.3, Expect=1e-12]} {Dmel: FBgn0013997, Nrx-IV, Neurexin IV, [Score=63.5, Expect=6e-11]} {Celegans: WBGene00003772, nlr-1, Neurexin Like receptor, [Score=60.8, Expect=3e-10]} {Smed: dd_Smed_v6_2622_0_1, dd_Smed_v6_2622_0_1, [Score=70.5, Expect=2e-13]} {RNA1509_12135} {RNA1310_13292} {RNA815_6015.1} |
27. | MligTC455_24661 | 112 | 2.33 | Mlig455_019924 | Neo: - Age: Down-Up-Down Region-enriched R8: 5.668/0.00712 |
URGCP | 0.971 | 0.971 | - | - | - | - | - | Mlig455_019924 {REF} {Length: 10713} {TRANSSPLICED} {Pfam: Dynamin family [PF00350.25, score=30.5]; Guanylate-binding protein, N-terminal domain [PF02263.21, score=23.0]; 50S ribosome-binding GTPase [PF01926.25, score=21.4]} {Human: ENSG00000106608, URGCP, upregulator of cell proliferation, [Score=171, Expect=3e-42]} {Mouse: ENSMUSG00000045868, Gvin1, GTPase, very large interferon inducible 1, [Score=397, Expect=5e-111]; ENSMUSG00000078606, Gm4070, predicted gene 4070, [Score=397, Expect=5e-111]} {RNA1509_14577, RNA1509_25042, RNA1509_25783, RNA1509_41509, RNA1509_46967, RNA1509_6932} {RNA1310_285, RNA1509_14577, RNA1509_25042, RNA1509_25783, RNA1509_41509, RNA1509_46967, RNA1509_6932} {RNA1509_14577, RNA1509_25042, RNA1509_25783, RNA1509_41509, RNA1509_46967, RNA1509_6932, RNA815_97.1} |
28. | MligTC455_41805 | 2256 | 47 | Mlig455_015764, Mlig455_049489 | Neo: - Age: - Region-specific R8: 2.792 Region-enriched R8: 2.927/0.00000 |
PKD2 | 0.971 | 0.971 | - | - | - | - | - | Mlig455_015764 {REF} {Length: 3347} {Pfam: Polycystin cation channel [PF08016.14, score=395.7]; Ion transport protein [PF00520.33, score=60.8]; EF hand [PF00036.34, score=22.8]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [Score=618, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [Score=617, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=255, Expect=3e-72]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=338, Expect=2e-104]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [Score=660, Expect=0.0]} {RNA1509_31010} {RNA1310_4653.2} {RNA815_18688} Mlig455_049489 {REF} {Length: 3379} {Pfam: Polycystin cation channel [PF08016.14, score=493.3]; Ion transport protein [PF00520.33, score=89.5]; EF hand [PF00036.34, score=27.1]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]; EF-hand domain [PF13405.8, score=18.5]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=716, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=711, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=306, Expect=1e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=387, Expect=1e-122]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=739, Expect=0.0]} {RNA1509_31010, RNA1509_51627} {RNA1310_4653.1, RNA1509_31010, RNA1509_51627} {RNA1509_31010, RNA1509_51627, RNA815_4316} |
29. | MligTC455_14600 | 206 | 4.29 | Mlig455_038122, Mlig455_039790 | Neo: - Age: - Region-enriched R8: 4.975/0.00049 |
IGFALS | 0.969 | 0.969 | - | - | - | - | - | Mlig455_038122 {REF} {Length: 2842} {Pfam: Leucine rich repeat [PF13855.8, score=265.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=153.7]; Leucine-rich repeat [PF14580.8, score=67.1]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=59.8]; Leucine Rich Repeat [PF00560.35, score=56.6]; Leucine Rich repeat [PF13516.8, score=43.5]} {Human: ENSG00000099769, IGFALS, insulin like growth factor binding protein acid labile subunit, [Score=156, Expect=3e-39]} {Mouse: ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [RH, Score=160, Expect=8e-41]} {Dmel: FBgn0261269, conv, convoluted, [RH, Score=136, Expect=2e-32]} {Celegans: WBGene00016974, lron-15, ELRR (Extracellular Leucine-Rich Repeat) ONly, [RH, Score=149, Expect=1e-36]} {Smed: dd_Smed_v6_2769_0_1, dd_Smed_v6_2769_0_1, [RH, Score=95.9, Expect=2e-20]} {RNA1310_36223} {RNA815_24524} Mlig455_039790 {REF} {Length: 2820} {Pfam: Leucine rich repeat [PF13855.8, score=265.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=153.7]; Leucine-rich repeat [PF14580.8, score=67.1]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=59.8]; Leucine Rich Repeat [PF00560.35, score=56.6]; Leucine Rich repeat [PF13516.8, score=43.5]} {Human: ENSG00000099769, IGFALS, insulin like growth factor binding protein acid labile subunit, [Score=156, Expect=3e-39]} {Mouse: ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [RH, Score=160, Expect=7e-41]} {Dmel: FBgn0261269, conv, convoluted, [RH, Score=135, Expect=2e-32]} {Celegans: WBGene00016974, lron-15, ELRR (Extracellular Leucine-Rich Repeat) ONly, [RH, Score=149, Expect=1e-36]} {Smed: dd_Smed_v6_2769_0_1, dd_Smed_v6_2769_0_1, [RH, Score=96.3, Expect=2e-20]} {RNA1310_36223} {RNA815_24524} |
30. | MligTC455_23517 | 847 | 17.64 | Mlig455_027857 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.877 Region-enriched R8: 5.900/0.00000 |
TLL1 | 0.969 | 0.969 | - | - | - | - | - | Mlig455_027857 {REF} {Length: 1443} {Pfam: Astacin (Peptidase family M12A) [PF01400.26, score=138.1]} {Human: ENSG00000038295, TLL1, tolloid like 1, [Score=95.9, Expect=7e-22]} {Mouse: ENSMUSG00000053626, Tll1, tolloid-like, [Score=94.7, Expect=4e-21]} {Dmel: FBgn0037395, CG10280, [Score=102, Expect=1e-24]} {Celegans: WBGene00003534, nas-15, Zinc metalloproteinase nas-15, [Score=119, Expect=6e-30]} {Smed: dd_Smed_v6_345_0_1, dd_Smed_v6_345_0_1, [RH, Score=124, Expect=7e-34]} {RNA1509_35571} {RNA1310_3360.1} {RNA815_11450} |
31. | MligTC455_37711 | 41 | 0.86 | Mlig455_009915 | Neo: - Age: - |
0.969 | 0.969 | - | - | - | - | - | Mlig455_009915 {REF} {Length: 1326} {RNA1509_26004} {RNA1310_89855.1} {RNA815_1664.2} | |
32. | MligTC455_38303 | 142 | 2.96 | Mlig455_021803 | Neo: - Age: Up-Down-Down |
PCLO | 0.968 | 0.968 | - | - | - | - | - | Mlig455_021803 {REF} {Length: 6090} {Pfam: C2 domain [PF00168.32, score=66.7]; FYVE-type zinc finger [PF02318.18, score=55.2]; Piccolo Zn-finger [PF05715.15, score=27.5]} {Human: ENSG00000186472, PCLO, piccolo presynaptic cytomatrix protein, [RH, Score=122, Expect=6e-27]} {Mouse: ENSMUSG00000061601, Pclo, piccolo (presynaptic cytomatrix protein), [RH, Score=119, Expect=2e-26]} {Dmel: FBgn0053547, Rim, Rab3 interacting molecule, [Score=83.2, Expect=1e-15]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [Score=79.0, Expect=1e-14]} {Smed: dd_Smed_v6_9615_0_1, dd_Smed_v6_9615_0_1, [RH, Score=185, Expect=4e-47]} {RNA1509_42665} {RNA1310_6999} {RNA815_17846} |
33. | MligTC455_48806 | 291 | 6.07 | Mlig455_026095, Mlig455_043131 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.405 Region-enriched R8: 3.032/0.00015 |
TCF4 | 0.968 | 0.968 | - | - | - | - | - | Mlig455_026095 {REF} {Length: 3455} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=33.4]} {Human: ENSG00000196628, TCF4, transcription factor 4, [RH, Score=157, Expect=2e-40]; ENSG00000140262, TCF12, transcription factor 12, [RH, Score=156, Expect=1e-39]} {Mouse: ENSMUSG00000053477, Tcf4, transcription factor 4, [RH, Score=157, Expect=7e-41]; ENSMUSG00000032228, Tcf12, transcription factor 12, [RH, Score=156, Expect=1e-39]; ENSMUSG00000020167, Tcf3, transcription factor 3, [RH, Score=151, Expect=3e-38]} {Dmel: FBgn0267821, da, daughterless, [Score=148, Expect=5e-37]} {Celegans: WBGene00001949, hlh-2, Helix Loop Helix, [Score=97.8, Expect=1e-21]} {Smed: dd_Smed_v6_5579_0_1, dd_Smed_v6_5579_0_1, [Score=165, Expect=4e-43]} {RNA1310_14993.1} {RNA815_4995.1} Mlig455_043131 {REF} {Length: 3692} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=41.4]} {Human: ENSG00000196628, TCF4, transcription factor 4, [Score=139, Expect=3e-34]; ENSG00000140262, TCF12, transcription factor 12, [Score=134, Expect=4e-32]; ENSG00000071564, TCF3, transcription factor 3, [Score=133, Expect=5e-32]} {Mouse: ENSMUSG00000053477, Tcf4, transcription factor 4, [Score=139, Expect=1e-34]; ENSMUSG00000032228, Tcf12, transcription factor 12, [Score=134, Expect=2e-32]; ENSMUSG00000020167, Tcf3, transcription factor 3, [Score=134, Expect=1e-32]} {Dmel: FBgn0267821, da, daughterless, [Score=122, Expect=8e-29]} {Celegans: WBGene00001949, hlh-2, Helix Loop Helix, [Score=83.6, Expect=6e-17]} {Smed: dd_Smed_v6_5579_0_1, dd_Smed_v6_5579_0_1, [Score=140, Expect=1e-34]} {RNA1310_14993.1} {RNA815_4995.1} |
34. | MligTC455_25854 | 1015 | 21.15 | Mlig455_052672 | Neo: - Age: logFC(26M/2M)=-0.640 Region-specific R8: 3.800 Region-enriched R8: 3.703/0.00000 Regeneration-downregulated BL: -2.563 Regeneration-depleted BL: -2.563 |
0.967 | 0.967 | - | - | - | - | - | Mlig455_052672 {REF} {Length: 1364} {Pfam: PLAC8 family [PF04749.19, score=60.9]} {Smed: dd_Smed_v6_865_0_1, dd_Smed_v6_865_0_1, [Score=98.2, Expect=1e-26]} {RNA1509_58157} {RNA1310_24348, RNA1509_58157} {RNA1509_58157, RNA815_10637.1} | |
35. | MligTC455_38827 | 168 | 3.49 | Mlig455_065185 | Neo: - Age: - Region-enriched R8: 3.346/0.01415 |
RDX | 0.965 | 0.965 | - | - | - | - | - | Mlig455_065185 {REF} {Length: 3409} {Pfam: Ezrin/radixin/moesin family [PF00769.21, score=106.5]; FERM C-terminal PH-like domain [PF09380.12, score=87.8]; FERM central domain [PF00373.20, score=83.0]; FERM N-terminal domain [PF09379.12, score=66.5]} {Human: ENSG00000137710, RDX, radixin, [RH, Score=589, Expect=0.0]; ENSG00000092820, EZR, ezrin, [RH, Score=577, Expect=0.0]; ENSG00000147065, MSN, moesin, [RH, Score=561, Expect=0.0]} {Mouse: ENSMUSG00000032050, Rdx, radixin, [RH, Score=586, Expect=0.0]; ENSMUSG00000031207, Msn, moesin, [RH, Score=557, Expect=0.0]} {Dmel: FBgn0011661, Moe, Moesin, [RH, Score=514, Expect=5e-174]} {Celegans: WBGene00001333, erm-1, ERM-1B; Ezrin/Radixin/Moesin, [Score=545, Expect=0.0]} {Smed: dd_Smed_v6_8101_0_1, dd_Smed_v6_8101_0_1, [Score=504, Expect=7e-172]} {RNA1509_50666} {RNA1310_19690} {RNA815_6880} |
36. | MligTC455_48650 | 8593 | 179.02 | Mlig455_043924 | Neo: - Age: logFC(26M/2M)=-0.454 Region-enriched R8: 6.377/0.00000 |
0.965 | 0.965 | - | - | - | - | - | Mlig455_043924 {REF} {Length: 1776} {RNA1509_3829} {RNA1310_39915.1, RNA1509_3829} {RNA1509_3829, RNA815_21876} | |
37. | MligTC455_19934 | 704 | 14.66 | Mlig455_001454 | Neo: - Age: - Region-enriched R8: 4.340/0.00000 |
HOXA10 | 0.964 | 0.964 | - | - | - | - | - | Mlig455_001454 {REF} {Length: 2331} {Pfam: Homeodomain [PF00046.31, score=71.5]; Protein of unknown function (DUF2722) [PF10846.10, score=21.4]; Anti-sigma-K factor rskA [PF10099.11, score=20.2]} {Human: ENSG00000253293, HOXA10, homeobox A10, [RH, Score=97.4, Expect=1e-21]; ENSG00000128713, HOXD11, homeobox D11, [RH, Score=95.5, Expect=2e-21]; ENSG00000170178, HOXD12, homeobox D12, [RH, Score=95.1, Expect=9e-22]; ENSG00000123407, HOXC12, homeobox C12, [RH, Score=94.7, Expect=2e-21]; ENSG00000180818, HOXC10, homeobox C10, [RH, Score=94.4, Expect=6e-21]; ENSG00000005073, HOXA11, homeobox A11, [RH, Score=92.8, Expect=2e-20]; ENSG00000128710, HOXD10, homeobox D10, [RH, Score=92.8, Expect=2e-20]} {Mouse: ENSMUSG00000000938, Hoxa10, homeobox A10, [RH, Score=97.8, Expect=5e-22]; ENSMUSG00000042499, Hoxd11, homeobox D11, [RH, Score=95.9, Expect=1e-21]; ENSMUSG00000050328, Hoxc12, homeobox C12, [RH, Score=94.7, Expect=1e-21]; ENSMUSG00000022484, Hoxc10, homeobox C10, [RH, Score=94.4, Expect=5e-21]; ENSMUSG00000001823, Hoxd12, homeobox D12, [RH, Score=94.4, Expect=1e-21]; ENSMUSG00000050368, Hoxd10, homeobox D10, [RH, Score=93.2, Expect=1e-20]} {Dmel: FBgn0000015, Abd-B, Abdominal B, [RH, Score=106, Expect=7e-25]} {Celegans: WBGene00004024, php-3, Posterior Hox gene Paralog, [RH, Score=104, Expect=2e-25]} {Smed: dd_Smed_v6_9061_0_1, dd_Smed_v6_9061_0_1, [RH, Score=132, Expect=2e-34]} {RNA1509_50329} {RNA1310_36793} {RNA815_27715} |
38. | MligTC455_21657 | 84 | 1.76 | Mlig455_048610 | Neo: - Age: - |
LMO1 | 0.964 | 0.964 | - | - | - | - | - | Mlig455_048610 {REF} {Length: 2071} {Pfam: LIM domain [PF00412.24, score=90.0]} {Human: ENSG00000166407, LMO1, LIM domain only 1, [RH, Score=186, Expect=1e-60]; ENSG00000048540, LMO3, LIM domain only 3, [RH, Score=183, Expect=2e-59]} {Mouse: ENSMUSG00000036111, Lmo1, LIM domain only 1, [RH, Score=183, Expect=1e-59]; ENSMUSG00000030226, Lmo3, LIM domain only 3, [RH, Score=183, Expect=1e-59]} {Dmel: FBgn0265598, Bx, Beadex, [RH, Score=198, Expect=1e-62]} {Celegans: WBGene00002987, lim-4, LIM domain family; Putative transcription factor LIM-4, [Score=79.3, Expect=7e-18]} {Smed: dd_Smed_v6_17422_0_1, dd_Smed_v6_17422_0_1, [RH, Score=140, Expect=6e-42]} {RNA1310_56294} {RNA815_40845} |
39. | MligTC455_30850 | 34 | 0.71 | Mlig455_019341, Mlig455_019556 | Neo: - Age: logFC(26M/2M)=-0.625 |
GRIK2, GRIK4 | 0.964 | 0.964 | - | - | - | - | - | Mlig455_019341 {REF} {Length: 3886} {Pfam: Ligand-gated ion channel [PF00060.28, score=95.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=54.6]; Receptor family ligand binding region [PF01094.30, score=53.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=24.1]; Iron-containing alcohol dehydrogenase [PF13685.8, score=22.3]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=160, Expect=8e-40]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=157, Expect=6e-39]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=152, Expect=3e-37]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=160, Expect=4e-40]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=155, Expect=2e-38]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=153, Expect=6e-38]} {Dmel: FBgn0039927, CG11155, [Score=179, Expect=3e-46]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=136, Expect=1e-32]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=257, Expect=5e-78]} {RNA1509_10728} {RNA1310_122.1} {RNA815_8415.1} Mlig455_019556 {REF} {Length: 4135} {Pfam: Ligand-gated ion channel [PF00060.28, score=96.3]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=54.5]; Receptor family ligand binding region [PF01094.30, score=39.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=24.1]; Iron-containing alcohol dehydrogenase [PF13685.8, score=19.4]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=155, Expect=3e-38]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=150, Expect=8e-37]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=149, Expect=2e-36]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=154, Expect=5e-38]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=149, Expect=1e-36]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=149, Expect=1e-36]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=147, Expect=4e-36]} {Dmel: FBgn0039927, CG11155, [Score=169, Expect=3e-43]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=136, Expect=1e-32]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=259, Expect=1e-78]} {RNA1509_10728} {RNA1310_31364} {RNA815_8415.1} |
40. | MligTC455_28752 | 111 | 2.31 | Mlig455_024556, Mlig455_024588, Mlig455_062242 | Neo: - Age: - Region-enriched R8: 3.725/0.03239 |
0.962 | 0.962 | - | - | - | - | - | Mlig455_024556 {REF} {Length: 953} {RNA1509_27801} {RNA1310_32897} {RNA815_15953.1} Mlig455_024588 {REF} {Length: 365} {RNA1310_65985} {RNA815_44318} Mlig455_062242 {REF} {Length: 2999} {Pfam: Salt tolerance down-regulator [PF13945.8, score=20.0]} {RNA1509_54152} {RNA1310_6101.1} {RNA815_15953.1} |
|
41. | MligTC455_33475 | 168 | 3.5 | Mlig455_036879 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.551 Region-enriched R8: 7.210/0.00005 |
0.962 | 0.962 | - | - | - | - | - | Mlig455_036879 {REF} {Length: 2954} {RNA1509_20567} {RNA1310_1034.1} {RNA815_502.1} | |
42. | MligTC455_27571 | 65 | 1.36 | Mlig455_035134 | Neo: - Age: logFC(26M/2M)=-0.443 Region-enriched R7: 3.058/0.04041 Regeneration-downregulated TP: -8.493 Regeneration-depleted TP: -8.493 |
ANK1 | 0.958 | 0.958 | - | - | - | - | - | Mlig455_035134 {REF} {Length: 4051} {Pfam: Ankyrin repeat [PF00023.32, score=192.6]; Ankyrin repeats (3 copies) [PF12796.9, score=186.4]; Ankyrin repeat [PF13606.8, score=143.1]; Ankyrin repeats (many copies) [PF13637.8, score=131.9]; Ankyrin repeats (many copies) [PF13857.8, score=129.4]; Mab-21 protein [PF03281.16, score=28.2]; Glutamine amidotransferase domain [PF13537.8, score=28.0]; PEGA domain [PF08308.13, score=20.0]} {Human: ENSG00000029534, ANK1, ankyrin 1, [Score=183, Expect=3e-46]} {Mouse: ENSMUSG00000031543, Ank1, ankyrin 1, erythroid, [Score=179, Expect=2e-45]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=173, Expect=2e-43]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=172, Expect=3e-43]} {Smed: dd_Smed_v6_10835_0_2, dd_Smed_v6_10835_0_2, [Score=179, Expect=1e-45]} {RNA1509_26004} {RNA1310_3906.1} {RNA815_1664.1} |
43. | MligTC455_54070 | 186 | 3.88 | Mlig455_067817 | Neo: - Age: - Region-enriched R8: 3.779/0.00038 |
OTOF | 0.957 | 0.957 | - | - | - | - | - | Mlig455_067817 {REF} {Length: 8297} {Pfam: C2 domain [PF00168.32, score=144.2]; FerB (NUC096) domain [PF08150.14, score=94.3]; FerI (NUC094) domain [PF08151.14, score=59.3]} {Human: ENSG00000115155, OTOF, otoferlin, [Score=829, Expect=0.0]} {Mouse: ENSMUSG00000062372, Otof, otoferlin, [Score=834, Expect=0.0]} {Dmel: FBgn0266757, mfr, misfire, [Score=114, Expect=3e-25]} {Celegans: WBGene00001414, fer-1, Sperm vesicle fusion protein fer-1, [Score=84.3, Expect=6e-16]} {Smed: dd_Smed_v6_5915_0_1, dd_Smed_v6_5915_0_1, [Score=1263, Expect=0.0]} {RNA1509_37008} {RNA1310_908.1} {RNA815_16140} |
44. | MligTC455_20404 | 2355 | 49.05 | Mlig455_053980 | Neo: - Age: - Region-enriched R7: 4.495/0.00000 Regeneration-downregulated BL: -4.662 Regeneration-depleted BL: -4.662 |
0.956 | 0.956 | - | - | - | - | - | Mlig455_053980 {REF} {Length: 505} {NoTransDecoderORF} {RNA1509_5548} {RNA1310_94516} {RNA815_53532} | |
45. | MligTC455_28564 | 383 | 7.97 | Mlig455_010532, Mlig455_061843 | Neo: - Age: - Region-enriched R8: 4.824/0.00000 |
KCNJ12 | 0.956 | 0.956 | - | - | - | - | - | Mlig455_010532 {REF} {Length: 1728} {Pfam: Inward rectifier potassium channel C-terminal domain [PF17655.3, score=178.4]; Inward rectifier potassium channel transmembrane domain [PF01007.22, score=147.1]} {Human: ENSG00000184185, KCNJ12, potassium voltage-gated channel subfamily J member 12, [Score=260, Expect=1e-83]; ENSG00000260458, KCNJ18, potassium voltage-gated channel subfamily J member 18, [Score=256, Expect=4e-82]} {Mouse: ENSMUSG00000042529, Kcnj12, potassium inwardly-rectifying channel, subfamily J, member 12, [Score=261, Expect=3e-84]; ENSMUSG00000044216, Kcnj4, potassium inwardly-rectifying channel, subfamily J, member 4, [Score=251, Expect=7e-80]} {Dmel: FBgn0265042, Irk1, Inwardly rectifying potassium channel 1, [Score=256, Expect=2e-81]} {Celegans: WBGene00002150, irk-2, Inward Rectifying K (Potassium) channel family, [Score=246, Expect=5e-78]} {RNA1509_57087} {RNA1310_22528} {RNA815_8424.1} Mlig455_061843 {REF} {Length: 1636} {Pfam: Inward rectifier potassium channel C-terminal domain [PF17655.3, score=194.7]; Inward rectifier potassium channel transmembrane domain [PF01007.22, score=167.7]} {Human: ENSG00000184185, KCNJ12, potassium voltage-gated channel subfamily J member 12, [Score=314, Expect=6e-104]; ENSG00000260458, KCNJ18, potassium voltage-gated channel subfamily J member 18, [Score=311, Expect=1e-102]} {Mouse: ENSMUSG00000042529, Kcnj12, potassium inwardly-rectifying channel, subfamily J, member 12, [Score=315, Expect=1e-104]; ENSMUSG00000044216, Kcnj4, potassium inwardly-rectifying channel, subfamily J, member 4, [Score=301, Expect=1e-98]} {Dmel: FBgn0265042, Irk1, Inwardly rectifying potassium channel 1, [Score=310, Expect=2e-101]} {Celegans: WBGene00002150, irk-2, Inward Rectifying K (Potassium) channel family, [Score=297, Expect=3e-97]} {RNA1509_57087} {RNA1310_22528} {RNA815_8424.1} |
46. | MligTC455_46217 | 213 | 4.43 | Mlig455_057532 | Neo: - Age: Down-Up-Down |
RBPMS2 | 0.956 | 0.956 | - | - | - | - | - | Mlig455_057532 {REF} {Length: 5470} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=53.4]} {Human: ENSG00000166831, RBPMS2, RNA binding protein, mRNA processing factor 2, [RH, Score=128, Expect=2e-35]} {Mouse: ENSMUSG00000031586, Rbpms, RNA binding protein gene with multiple splicing, [RH, Score=125, Expect=3e-35]} {Dmel: FBgn0263995, cpo, couch potato, [Score=164, Expect=7e-46]} {Celegans: WBGene00003172, mec-8, Mec-8 protein, [Score=124, Expect=4e-33]} {Smed: dd_Smed_v6_4296_0_4, dd_Smed_v6_4296_0_4, [Score=150, Expect=3e-43]} {RNA1509_30119} {RNA1310_16586.1} {RNA815_23894} |
47. | MligTC455_48954 | 316 | 6.59 | Mlig455_000336, Mlig455_067936 | Neo: - Age: - Region-enriched R8: 6.016/0.00000 |
WNT2 | 0.956 | 0.956 | - | - | - | - | - | Mlig455_000336 {REF} {Length: 2268} {Pfam: wnt family [PF00110.21, score=150.7]} {Human: ENSG00000105989, WNT2, Wnt family member 2, [Score=94.4, Expect=1e-20]; ENSG00000162552, WNT4, Wnt family member 4, [Score=92.8, Expect=3e-20]} {Mouse: ENSMUSG00000010797, Wnt2, wingless-type MMTV integration site family, member 2, [Score=95.1, Expect=4e-21]; ENSMUSG00000036856, Wnt4, wingless-type MMTV integration site family, member 4, [Score=93.2, Expect=2e-20]} {Dmel: FBgn0010453, Wnt4, Wnt oncogene analog 4, [Score=75.5, Expect=3e-14]} {Celegans: WBGene00000857, cwn-1, [Score=95.5, Expect=2e-21]} {Smed: dd_Smed_v6_14391_0_1, dd_Smed_v6_14391_0_1, [RH, Score=137, Expect=4e-36]} {RNA1509_39977} {RNA1310_11459, RNA1509_39977} {RNA1509_39977, RNA815_18855} Mlig455_067936 {REF} {Length: 2361} {Pfam: wnt family [PF00110.21, score=149.2]} {Human: ENSG00000105989, WNT2, Wnt family member 2, [Score=96.7, Expect=2e-21]; ENSG00000162552, WNT4, Wnt family member 4, [Score=92.0, Expect=6e-20]} {Mouse: ENSMUSG00000010797, Wnt2, wingless-type MMTV integration site family, member 2, [Score=97.4, Expect=7e-22]} {Dmel: FBgn0010453, Wnt4, Wnt oncogene analog 4, [Score=75.5, Expect=3e-14]} {Celegans: WBGene00000857, cwn-1, [Score=96.3, Expect=1e-21]} {Smed: dd_Smed_v6_14391_0_1, dd_Smed_v6_14391_0_1, [RH, Score=133, Expect=7e-35]} {RNA1509_39977} {RNA1310_11459} {RNA815_18855} |
48. | MligTC455_20407 | 5467 | 113.89 | Mlig455_054055 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.662 Region-enriched R7: 3.793/0.00000 Regeneration-downregulated BL: -5.435 Regeneration-depleted BL: -5.435 |
0.955 | 0.955 | - | - | - | - | - | Mlig455_054055 {REF} {Length: 1179} {RNA1509_40983} {RNA1310_94516} {RNA815_53532} | |
49. | MligTC455_25852 | 257 | 5.35 | Mlig455_026376 | Neo: - Age: Down-Up-Down Region-enriched R7: 2.913/0.04400 |
0.955 | 0.955 | - | - | - | - | - | Mlig455_026376 {REF} {Length: 1440} {Pfam: PLAC8 family [PF04749.19, score=60.9]} {Smed: dd_Smed_v6_865_0_1, dd_Smed_v6_865_0_1, [Score=98.2, Expect=1e-26]} {RNA1509_36976} {RNA1310_18646} {RNA815_10637.1} | |
50. | MligTC455_27472 | 133 | 2.77 | Mlig455_009912 | Neo: - Age: logFC(26M/2M)=-0.500 Region-enriched R8: 4.558/0.00009 |
ANK1 | 0.955 | 0.955 | - | - | - | - | - | Mlig455_009912 {REF} {Length: 4603} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=223.1]; Ankyrin repeat [PF00023.32, score=210.6]; Ankyrin repeats (many copies) [PF13637.8, score=152.3]; Ankyrin repeat [PF13606.8, score=151.1]; Ankyrin repeats (many copies) [PF13857.8, score=122.9]; Glutamine amidotransferase domain [PF13537.8, score=29.6]; Mab-21 protein [PF03281.16, score=29.0]} {Human: ENSG00000029534, ANK1, ankyrin 1, [Score=194, Expect=1e-49]} {Mouse: ENSMUSG00000031543, Ank1, ankyrin 1, erythroid, [Score=183, Expect=2e-46]; ENSMUSG00000044864, Ankrd50, ankyrin repeat domain 50, [Score=181, Expect=9e-46]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=177, Expect=2e-44]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=171, Expect=1e-44]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=177, Expect=1e-44]} {Smed: dd_Smed_v6_2072_0_4, dd_Smed_v6_2072_0_4, [Score=187, Expect=5e-48]} {RNA1509_26004} {RNA1310_3906.1} {RNA815_1664.1} |
51. | MligTC455_28563 | 196 | 4.09 | Mlig455_061802 | Neo: - Age: Up-Down-Down Region-enriched R8: 4.606/0.00003 |
KCNJ12 | 0.955 | 0.955 | - | - | - | - | - | Mlig455_061802 {REF} {Length: 5059} {Pfam: Inward rectifier potassium channel C-terminal domain [PF17655.3, score=194.7]; Inward rectifier potassium channel transmembrane domain [PF01007.22, score=168.7]} {Human: ENSG00000184185, KCNJ12, potassium voltage-gated channel subfamily J member 12, [Score=315, Expect=3e-104]; ENSG00000260458, KCNJ18, potassium voltage-gated channel subfamily J member 18, [Score=311, Expect=8e-103]; ENSG00000123700, KCNJ2, potassium voltage-gated channel subfamily J member 2, [Score=300, Expect=1e-98]} {Mouse: ENSMUSG00000042529, Kcnj12, potassium inwardly-rectifying channel, subfamily J, member 12, [Score=316, Expect=6e-105]; ENSMUSG00000044216, Kcnj4, potassium inwardly-rectifying channel, subfamily J, member 4, [Score=301, Expect=6e-99]} {Dmel: FBgn0265042, Irk1, Inwardly rectifying potassium channel 1, [Score=311, Expect=9e-102]} {Celegans: WBGene00002150, irk-2, Inward Rectifying K (Potassium) channel family, [Score=296, Expect=4e-97]} {RNA1509_57087} {RNA1310_22528, RNA1509_57087} {RNA1509_57087, RNA815_8424.1} |
52. | MligTC455_13091 | 105 | 2.18 | Mlig455_005443 | Neo: - Age: - |
0.954 | 0.954 | - | - | - | - | - | Mlig455_005443 {REF} {Length: 2879} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=31.3]} {RNA1509_41201} {RNA1310_51571} {RNA815_38501} | |
53. | MligTC455_21451 | 352 | 7.34 | Mlig455_040118, Mlig455_067333 | Neo: - Age: - Region-enriched R8: 6.038/0.00000 |
ANGPTL7 | 0.954 | 0.954 | - | - | - | - | - | Mlig455_040118 {REF} {Length: 1728} {tRNA: Val(CAC),pseudo, score=20.9} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=127.6]; PAN domain [PF00024.28, score=20.2]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=98.6, Expect=3e-23]; ENSG00000120332, TNN, tenascin N, [Score=98.2, Expect=2e-22]; ENSG00000171564, FGB, fibrinogen beta chain, [Score=96.7, Expect=5e-22]; ENSG00000116147, TNR, tenascin R, [Score=96.7, Expect=8e-22]; ENSG00000160339, FCN2, ficolin 2, [Score=94.0, Expect=5e-22]} {Mouse: ENSMUSG00000026725, Tnn, tenascin N, [Score=97.8, Expect=2e-22]; ENSMUSG00000015829, Tnr, tenascin R, [Score=97.8, Expect=2e-22]; ENSMUSG00000033831, Fgb, fibrinogen beta chain, [Score=95.9, Expect=5e-22]; ENSMUSG00000026938, Fcna, ficolin A, [Score=95.5, Expect=2e-22]; ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=94.0, Expect=8e-22]} {Dmel: FBgn0050280, CG30280, [Score=111, Expect=9e-29]} {Celegans: WBGene00020516, T15B7.1, [Score=68.2, Expect=6e-13]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=100, Expect=8e-24]} {RNA1509_58115} {RNA1310_32877} {RNA815_17241} Mlig455_067333 {REF} {Length: 1595} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=128.2]; PAN domain [PF00024.28, score=20.3]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=99.8, Expect=1e-23]; ENSG00000120332, TNN, tenascin N, [Score=99.0, Expect=2e-22]; ENSG00000171564, FGB, fibrinogen beta chain, [Score=98.2, Expect=2e-22]; ENSG00000116147, TNR, tenascin R, [Score=97.1, Expect=7e-22]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=98.2, Expect=2e-22]; ENSMUSG00000026725, Tnn, tenascin N, [Score=97.8, Expect=3e-22]; ENSMUSG00000033831, Fgb, fibrinogen beta chain, [Score=97.4, Expect=2e-22]; ENSMUSG00000026938, Fcna, ficolin A, [Score=95.5, Expect=3e-22]; ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=94.4, Expect=6e-22]} {Dmel: FBgn0050280, CG30280, [Score=111, Expect=8e-29]} {Celegans: WBGene00020516, T15B7.1, [Score=68.6, Expect=6e-13]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=101, Expect=4e-24]} {RNA1509_58115} {RNA1310_32877} {RNA815_17241} |
54. | MligTC455_51159 | 49 | 1.03 | Mlig455_068260 | Neo: - Age: - |
SSPO | 0.954 | 0.954 | - | - | - | - | - | Mlig455_068260 {REF} {Length: 3064} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=45.9]; C8 domain [PF08742.13, score=40.0]; von Willebrand factor type D domain [PF00094.27, score=26.1]} {Human: ENSG00000197558, SSPO, SCO-spondin, [Score=125, Expect=4e-29]} {Mouse: ENSMUSG00000029797, Sspo, SCO-spondin, [Score=115, Expect=6e-26]} {Dmel: FBgn0029167, Hml, Hemolectin, [Score=87.4, Expect=2e-17]} {Celegans: WBGene00003072, lrp-2, Low-density lipoprotein RecePtor related, [Score=61.6, Expect=2e-09]} {Smed: dd_Smed_v6_9342_0_1, dd_Smed_v6_9342_0_1, [Score=141, Expect=8e-35]} {RNA1509_32065} {RNA1310_11674.1} {RNA815_35239} |
55. | MligTC455_06773 | 251 | 5.23 | Mlig455_069732 | Neo: - Age: Down-Up-Down |
0.953 | 0.953 | - | - | - | - | - | Mlig455_069732 {REF} {Length: 1347} {RNA1310_24767.1} {RNA815_33473} | |
56. | MligTC455_12451 | 63 | 1.31 | Mlig455_008444 | Neo: - Age: - Region-enriched R8: 4.645/0.00722 |
0.952 | 0.952 | - | - | - | - | - | Mlig455_008444 {REF} {Length: 791} | |
57. | MligTC455_14757 | 726 | 15.12 | Mlig455_043399, Mlig455_043416, Mlig455_043559, Mlig455_043567 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.347 Region-specific R8: 6.849 Region-enriched R8: 6.705/0.00000 Regeneration-downregulated BL: -8.524 Regeneration-depleted BL: -8.524 |
0.952 | 0.952 | - | - | - | - | - | Mlig455_043399 {REF} {Length: 5997} {Dmel: FBgn0010434, cora, coracle, [Score=80.5, Expect=1e-14]} {RNA1509_17394} {RNA1310_20597} {RNA815_24724} Mlig455_043416 {REF} {Length: 6138} {RNA1509_17394} {RNA1310_20597} {RNA815_24724} Mlig455_043559 {REF} {Length: 7159} {RNA1509_17394} {RNA1310_38694} {RNA815_21047} Mlig455_043567 {REF} {Length: 8454} {Dmel: FBgn0010434, cora, coracle, [Score=51.6, Expect=3e-06]} {RNA1509_17394} {RNA1310_20597} {RNA815_24724} |
|
58. | MligTC455_06772 | 238 | 4.96 | Mlig455_048772 | Neo: - Age: - Region-enriched R8: 6.268/0.00000 |
0.951 | 0.951 | - | - | - | - | - | Mlig455_048772 {REF} {Length: 839} {RNA1310_24767.2} {RNA815_33473} | |
59. | MligTC455_40223 | 172 | 3.59 | Mlig455_016264 | Neo: - Age: - Region-enriched R8: 3.704/0.01076 |
CHRNA10 | 0.95 | 0.950 | - | - | - | - | - | Mlig455_016264 {REF} {Length: 4782} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=169.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.0]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=230, Expect=2e-68]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=225, Expect=1e-66]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=233, Expect=9e-70]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=236, Expect=2e-70]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=215, Expect=6e-63]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=280, Expect=9e-87]} {RNA1509_35668} {RNA1310_11720.1} {RNA815_6827} |
60. | MligTC455_46216 | 1117 | 23.28 | Mlig455_057440 | Neo: - Age: - Region-enriched R7: 2.350/0.00017 |
RBPMS2 | 0.95 | 0.950 | - | - | - | - | - | Mlig455_057440 {REF} {Length: 4543} {TRANSSPLICED} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=53.4]} {Human: ENSG00000166831, RBPMS2, RNA binding protein, mRNA processing factor 2, [RH, Score=128, Expect=2e-35]} {Mouse: ENSMUSG00000031586, Rbpms, RNA binding protein gene with multiple splicing, [RH, Score=125, Expect=3e-35]} {Dmel: FBgn0263995, cpo, couch potato, [Score=164, Expect=7e-46]} {Celegans: WBGene00003172, mec-8, Mec-8 protein, [Score=124, Expect=4e-33]} {Smed: dd_Smed_v6_4296_0_4, dd_Smed_v6_4296_0_4, [Score=150, Expect=3e-43]} {RNA1509_30119} {RNA1310_16586.1} {RNA815_23894} |